Skip to main content
. 2023 Sep 28;23:336. doi: 10.1186/s12876-023-02978-y

Table 1.

Comparison of baseline characteristics between the cases (flare of ulcerative colitis) and controls (remission)

Cases (n = 51)
N(%)
Controls (n = 33) p value
Age (years) 38 (24–49.3) 38 (25.5–48.53)
Male gender 27 (52.9%) 20 (60.6%) 0.509
Marital status (Married) 35 (68.6%) 24 (72.7%) 0.377
Extent

E1- 1 (1.9%)

E2- 8 (15.7%)

E3- 21 (41.1%)

UK- 21 (41.1%)

E1- 3 (9.1%)

E2- 7 (21.2%)

E3- 7 (21.2%)

UK-16 (48.5%)

0.163
Extraintestinal manifestations Yes- 11 (21.6%) Yes − 4 (7.8%) 0.381
Comorbidity Yes − 16 (31.4%) Yes-9 (27.3%) 0.808
Smokers 6 (11.8%) 1 (3%) 0.237
Alcohol use 8 (15.7%) 5 (15.2) 1.00
5 Aminosalicylates use 39 (76.5%) 30 (90.9%) 0.144
Thiopurine use 8 (15.7%) 12 (36.36%) 0.038
Biologics/small molecule use 1 (1.9%) 1 (3%) 1.0
Kuppuswamy scale (median) 10 8 0.25